NEW YORK (GenomeWeb News) – BG Medicine said today that it has raised $40 million in a Series D financing.
 
The privately held molecular diagnostics firm said the funding would enable it to complete development and commercialization of its first two diagnostic products and continue discovery and development of additional product candidates.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.